La Renon Healthcare Pvt. Ltd.is an Indian multinational pharmaceutical company with its headquarters in Ahmedabad, India. The company was founded in the year 2007 by Pankaj Singh and started its operation in the year 2008. It was incorporated as a private limited company on the 7th of August in the year 2007.The founder is also the Chairman and Managing Director of La Renon Healthcare. Singh has also been awarded with the "Pharma Leaders Innovative Business Leader of the Year 2019” for his work in the healthcare segment. His company La Renon Healthcare has evolved rapidly since its inception and has made it to the list of top fifty pharmaceutical companies of the country. It provides the treatment for chronic diseases. The company began its journey with the nephrology segment and chronic kidney disorders. It became the first company to foray into early kidney disease management. The company also has a strong presence in the central nervous system segment. Apart from the chronic disease segment, the company also intends to produce Active Pharmaceutical Ingredients. Singh started his career in the pharmaceutical industry several years back in 1994 with a company called Core Parenterals Limited. He was appointed as Professional Service Representative in the company. Singh resigned from his work at his previous company to start La Renon Healthcare Pvt. Ltd. At the time of its inception in the year 2008, the company had a total strength of only thirty employees.

The company specializes in the therapy areas of nephrology, critical care, neurological disorders, urology, gastroenterology, gynecology, respiratory disorders, central nervous system, cardio-metabolic and cardio-diabetic disorders.

La Renon Healthcare Pvt. Ltd. has its manufacturing facility located in Indore and Himachal Pradesh. The subsidiary at the latter called the Stanford Laboratory is responsible for the production of large amount of products of the company. The company has a wide international presence and has proliferated into major Latin American, Middle East, South-East Asian, African and CIS countries. Its global market comprises of countries like Germany, Ukraine, Malaysia, Vietnam, Philippines, Nepal, Myanmar, Cambodia, Singapore, Malawi, Zimbabwe, Ghana, Tanzania, Uganda, Mauritius, Kenya and Rwanda. The company also received funds worth Rs. 100 crore from Sequoia Capital for the betterment of its research facilities.

Some of the top products of the company include RENOLOG, NUHENZ, LEVIGRESS, PALMIGES, SOBISIS, QUOGRESS, COLIHENZ P, CIRROSAM, ANFOE, EIDO-FE, CUDO, FORTE, THIOTRES, ESOGRESS-D, GLUTAHENZ, LAMINO GI, LAMINO, COLIHENZ, ESOGRESS-L, LARETOL, PBREN-NT, JUVOBIN, IMMUTIL-S, CELIZAREN, LAREGAB-AT, LAMINO NEPHRO, LACARNIT, FERRONOMIC PLUS, XBAREN, RENOPRESS XL, LARINJECT, DIVALGRESS, TACROREN, PBREN, SEVLAREN, LANUM, LAREGAB-NT, IMMUTIL, GLIZIHENZ M, MESAHENZ, RIFAXIGRESS, OTSKI, NUHENZ-D, ENZISPOR, ZOACT, CEREHENZ, FERRONOMIC, ESCIGRESS-CZ, ESOGRESS, RENOQUE and NEURONOMIC.